BIOS enteredinto an agreement withLaboratorios PiSA S.A. de C.V(PiSA) of Mexico for the codevelopment and commercialisation of generic recombinant human insulin (rh insulin)fortheUSmarket.Webelievethedevelopmentisstrategic,asBIOScanusePiSA's...